Pfizer and Moderna want vaccine authorization by end of November
North American companies Pfizer and Moderna hope to obtain authorization to launch their covid-19 vaccines by the end of November in the United States, the AFP agency said on Friday.
If they achieve this goal, it will mean a record in vaccine development, nine months after the first death from the new coronavirus in that country, reports the agency.
Read more in Jornal de Notícias
This article is available in: Português